Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
telix
Healthcare Stocks Tech Stocks Technology
Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know
Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement with the U.S. Food and Drug Administration on the resubmission of its new drug application for TLX101-CDx (Pixclara), an imaging agent designed for glioma. What…
September 9, 20250Comments
clearvue
Uncategorized
Why ClearVue Technologies (ASX: CPV) Just Sparked Fresh Investor Excitement
ClearVue Technologies – Gen3 Solar Vision Glass Breakthrough ClearVue Technologies (ASX: CPV) turned heads this week after its share price surged more than 20 percent on the back of a breakthrough announcement. The company revealed that its Gen3 Solar Vision Glass prototype has been independently validated by the Solar Energy Research Institute of Singapore, confirming…
September 9, 20250Comments
metallium
Mining Stocks Small Caps Stocks Technology
Metallium (ASX: MTM) Lands First U.S. Defense Deal — Could This Be the Start of Something Big?
Metallium Breaks Into U.S. Defense Funding: A Small Contract with Big Implications Metallium (ASX: MTM) just landed its first U.S. Department of Defense contract, and while the value is only USD 100,000, the implications are far more significant. This Phase 1 Small Business Innovation Research award marks the company’s formal entry into the U.S. federal…
September 2, 20250Comments
woolworths
Blue Chip Stocks
Woolworths (ASX: WOW) Slips 15% After Profit Miss — Opportunity or Red Flag?
Woolworths Stumbles in FY25: Setback or Buying Opportunity? Woolworths (ASX: WOW) has long been seen as a reliable name on the market, but its FY25 results delivered a setback. Profitability fell short of expectations, and the share price dropped around 15 percent as investors reacted to weaker operating leverage and ongoing supply chain pressures flagged…
September 2, 20250Comments

Independent ASX research and stock analysis. Actionable investment ideas on ASX-listed stocks from analysts who call it straight.

Sectors
Quick Links
Learn

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here